JP2020513211A5 - - Google Patents

Download PDF

Info

Publication number
JP2020513211A5
JP2020513211A5 JP2019552584A JP2019552584A JP2020513211A5 JP 2020513211 A5 JP2020513211 A5 JP 2020513211A5 JP 2019552584 A JP2019552584 A JP 2019552584A JP 2019552584 A JP2019552584 A JP 2019552584A JP 2020513211 A5 JP2020513211 A5 JP 2020513211A5
Authority
JP
Japan
Prior art keywords
composition
mitochondrial
mitochondria
subject
hair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019552584A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020513211A (ja
JP7265992B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2018/050332 external-priority patent/WO2018178970A1/en
Publication of JP2020513211A publication Critical patent/JP2020513211A/ja
Publication of JP2020513211A5 publication Critical patent/JP2020513211A5/ja
Application granted granted Critical
Publication of JP7265992B2 publication Critical patent/JP7265992B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019552584A 2017-03-26 2018-03-22 皮膚および毛髪の治療のためのミトコンドリア組成物および方法 Active JP7265992B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762476792P 2017-03-26 2017-03-26
US62/476,792 2017-03-26
PCT/IL2018/050332 WO2018178970A1 (en) 2017-03-26 2018-03-22 Mitochondrial compositions and methods for treatment of skin and hair

Publications (3)

Publication Number Publication Date
JP2020513211A JP2020513211A (ja) 2020-05-07
JP2020513211A5 true JP2020513211A5 (cg-RX-API-DMAC7.html) 2021-04-30
JP7265992B2 JP7265992B2 (ja) 2023-04-27

Family

ID=63674350

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019552584A Active JP7265992B2 (ja) 2017-03-26 2018-03-22 皮膚および毛髪の治療のためのミトコンドリア組成物および方法

Country Status (5)

Country Link
US (2) US20200023005A1 (cg-RX-API-DMAC7.html)
EP (1) EP3600351A4 (cg-RX-API-DMAC7.html)
JP (1) JP7265992B2 (cg-RX-API-DMAC7.html)
IL (1) IL269401A (cg-RX-API-DMAC7.html)
WO (1) WO2018178970A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL282198B2 (en) 2011-09-11 2025-11-01 Minovia Therapeutics Ltd Compositions of functional mitochondria and uses thereof
WO2019186553A1 (en) * 2018-03-27 2019-10-03 Minovia Therapeutics Ltd. Methods for elevation of lipid and cholesterol metabolism
US12329781B2 (en) 2018-07-22 2025-06-17 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of renal diseases
EP3823644A4 (en) 2018-07-22 2022-06-08 Minovia Therapeutics Ltd. MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES
JP7524157B2 (ja) 2018-07-22 2024-07-29 ミノヴィア セラピューティクス リミテッド 脳疾患のミトコンドリア増強療法
WO2020021539A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of muscle diseases
US12502408B2 (en) 2018-07-22 2025-12-23 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy for primary mitochondrial diseases
WO2020021535A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of ocular diseases
JP7745544B2 (ja) 2019-10-24 2025-09-29 イメル バイオセラピューティクス,インク. ミトコンドリアdna中のマクロヘテロプラスミー及びミクロヘテロプラスミーを検出するための方法
TWI789723B (zh) * 2020-03-20 2023-01-11 台灣粒線體應用技術股份有限公司 粒線體用於治療或/及預防腎臟損傷相關疾病之用途
MX2022012157A (es) 2020-03-31 2023-02-15 Minovia Therapeutics Ltd Celulas geneticamente modificadas enriquecidas con mitocondrias y usos de estas.
KR102290596B1 (ko) * 2020-09-10 2021-08-19 주식회사 파이안바이오테크놀로지 분리된 미토콘드리아를 포함하는 주사용 조성물 및 이의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937348A1 (de) * 1999-08-11 2001-02-22 Aventis Cropscience Gmbh Nukleinsäuremoleküle aus Pflanzen codierend Enzyme, die an der Stärkesynthese beteiligt sind
JP2004500409A (ja) * 2000-03-31 2004-01-08 ザ ジェネラル ホスピタル コーポレーション 毛の成長を調節する方法
WO2003012050A2 (en) * 2001-07-31 2003-02-13 Northeastern University Mitochondrial genome replenishment
US7138134B2 (en) * 2001-12-18 2006-11-21 Arizona Health Consulting Group, Llc Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels
US20060024277A1 (en) * 2004-07-27 2006-02-02 Sivak Hannah N Method of skin care and/or treatment using extracts enriched in mitochondria
JP2006131600A (ja) * 2004-11-09 2006-05-25 R & D Cell-Science Optional Medico:Kk 発毛促進のためのヒト細胞組成物
AU2012201710B2 (en) * 2006-05-11 2014-01-16 Regenics As Administration of cells and cellular extracts for rejuvenation
IL282198B2 (en) * 2011-09-11 2025-11-01 Minovia Therapeutics Ltd Compositions of functional mitochondria and uses thereof
US10702556B2 (en) * 2012-05-16 2020-07-07 Minovia Therpautices Ltd. Compositions and methods for inducing angiogenesis
WO2014091312A2 (en) * 2012-12-10 2014-06-19 Regenics As Use of cellular extracts for skin rejuvenation
JP6441472B2 (ja) * 2014-09-30 2018-12-19 台灣粒線體應用技術股▲扮▼有限公司Taiwan Mitochondrion Applied Technology Co.,Ltd. 活性成分として外因性ミトコンドリアを含む組成物、ならびにその使用およびそのための細胞修復法
US20180030413A1 (en) * 2015-02-26 2018-02-01 Minovia Therapeutics Ltd. Mammalian cells enriched with functional mitochondria

Similar Documents

Publication Publication Date Title
US20230381227A1 (en) Mitochondrial compositions and methods for the treatment of skin and hair
JPS62246508A (ja) 発毛を刺激する方法
CN109908329A (zh) 毛囊细胞激活因子止脱生发制剂生产工艺及其用途
WO2020111047A1 (ja) 頭皮頭髪用組成物
KR20160035586A (ko) 치은 섬유모세포의 탈모증 치료 용도
Elgobashy et al. A review on androgenic alopecia: etiology, pathogenesis, pharmacological and non-pharmacological treatment approaches
CN113880961A (zh) 葡甘六糖、其制备方法、其应用和毛发再生制剂
Chakraborty et al. Stem-cell therapy in dermatology–Challenges and opportunities
CN113226339A (zh) 用于治疗脱发或促进毛发生长的组合物
Aduba et al. 0876 Tsc2 deletion in mesenchymal cells improves distal digit regeneration
Kosumi et al. 0872 Reserve transit-amplifying cells contribute to rapid tissue regeneration in nails
Nagalla et al. 0877 Activated wound phenotype and microbial dysbiosis are driven by AhR suppression in hidradenitis suppurativa tunnels
Linowiecka et al. 0875 Taxane chemotherapy induces premature aging and epigenetic changes in human hair follicles
Bernier et al. 0873 Modeling junctional epidermolysis bullosa using tissue-engineered skin substitutes
Ogawa et al. 0874 TGF-β signaling-mediated wound healing is required for hair follicle neogenesis
Garidou et al. 618 Efficacy of Silybum marianum fruit extract in inhibiting sebogenesis
Piccini et al. 682 Identification of novel potential therapeutic targets by comparative transcriptomic profiling of physiological and pathological skin wounds ex vivo
Pappalardo et al. 685 Modelling intrinsic and extrinsic cellular senescence in vitro with complex bioengineered human skin constructs
Cooper et al. 681 G-protein-coupled receptor 84 regulates acute inflammation in normal and diabetic skin wounds
Bianchi et al. 683 Wound healing improvement, by a topical formula containing oat concentrate and cicahyalumide, through the microbiota composition and the metabolite production modulation
Haberland et al. 680 MPZL3 is an epithelia-autonomous regulator of the murine hair cycle
Ogawa et al. 684 TGF-β signaling during the early phase of regeneration is required for wound-induced hair follicle neogenesis
TWI826829B (zh) 鹿茸萃取物用於毛髮修護與促進毛髮新生之用途
US20170049677A1 (en) Method for reversing hair loss and the loss of cuticle growth and density by administering effective courses of granulocyte-colony stimulating factor
Lorion et al. 619 Structural and biomechanical properties of a novel 3D microdermis model: the spheroid